Teva Pharmaceutical Industries (TEVA) Net Equity Issued and Repurchased (2015 - 2016)
Teva Pharmaceutical Industries' (TEVA) quarterly Net Equity Issued and Repurchased came in at $329.0 million in Q1 2016, down 90.0% on a QoQ basis from $3.3 billion in Q4 2015.
Teva Pharmaceutical Industries (TEVA) Net Equity Issued and Repurchased (2015 - 2016) Analysis & Trends
Teva Pharmaceutical Industries (TEVA) has 2 years of Net Equity Issued and Repurchased data on file, last reported at $329.0 million in Q1 2016.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $329.0 million in Q1 2016, while the trailing twelve-month figure through Dec 2016 was $329.0 million (down 90.0% YoY) and the FY2016 annual result came in at $329.0 million, down 90.0% from the prior year.
- Net Equity Issued and Repurchased eased to $329.0 million in Q1 2016, from $3.3 billion in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $3.3 billion in Q4 2015 to a low of $329.0 million in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.60 Bn | 42.64 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.50 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.66 Bn | 22.86 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.22 Bn | 19.55 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.69 Bn | 15.30 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.07 Bn | 9.91 Bn | - | - |
| 10 | Alkermes | 8.26 Bn | 7.60 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 329.00 Mn |
| Mar 31, 2016 | 329.00 Mn |
| Dec 31, 2015 | 3.29 Bn |
| Dec 31, 2015 | 3.29 Bn |